NDARECTALAEROSOL, METERED
Approved
Feb 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
5/8 — Partial
CORTIFOAM (hydrocortisone acetate) by Viatris is clinical pharmacology cortifoam provides effective topical administration of an anti-inflammatory corticosteroid as adjunctive therapy of ulcerative proctitis. First approved in 1982.
Drug data last refreshed 13h ago · AI intelligence enriched 16h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Cortifoam is a metered-dose rectal aerosol foam containing hydrocortisone acetate, a topical corticosteroid indicated as adjunctive therapy for ulcerative proctitis. The drug delivers anti-inflammatory corticosteroid action directly to the rectum, with penetration approximately 10 centimeters into the rectal tissue. It has been the standard rectal corticosteroid foam formulation since FDA approval in 1982.
$0.528MPart D
LOE ApproachingDeclining commercial relevance with approaching loss of exclusivity signals downsizing of brand support and transition focus to generic partnership or discontinuation planning.
Mechanism of Action
CLINICAL PHARMACOLOGY Cortifoam provides effective topical administration of an anti-inflammatory corticosteroid as adjunctive therapy of ulcerative proctitis. Direct observations of methylene blue-containing foam have shown staining about 10 centimeters into the rectum.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories
Started Mar 2016
16 enrolled
Healthy
Career Relevance
Cortifoam represents a career opportunity in mature product stewardship, regulatory maintenance, and generic transition planning within Viatris' gastroenterology portfolio. Professionals joining this product should expect responsibility for maximizing remaining exclusivity value, managing the LOE transition, and potentially supporting generic or authorized generic strategy.
Brand Manager
Worked on CORTIFOAM at Viatris? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.